FDA OKs Drug for Multiple Sclerosis

From the creator

The FDA has approved Ocrevus, a drug from Genentech and the first treatment for the most severe form of Multiple Sclerosis. WSJ's Tom Burton and Tanya Rivero discuss the nature of the medication and its high cost. Photo: AP Subscribe to the WSJ channel here: http://bit.ly/14Q81Xy More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com Follow WSJ on Facebook: http://www.facebook.com/wsjvideo Follow WSJ on Google+: https://plus.google.com/+wsj/posts Follow WSJ on Twitter: https://twitter.com/WSJvideo Follow WSJ on Instagram: http://instagram.com/wsj Follow WSJ on Pinterest: http://www.pinterest.com/wsj/ Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com Visit the WSJ Video Center: https://wsj.com/video On Facebook: https://www.facebook.com/pg/wsj/videos/ On Twitter: https://twitter.com/WSJ On Snapchat: https://on.wsj.com/2ratjSM

Published 2017-03-29 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.